K. Venkateswara Swamy

Author

Also Known As

K Swamy, K V Swamy, K Venkateswara Swamy, K. V. Swamy, K. Venkateswara Swamy, K. venkateswara Swamy, K.V. Swamy, K.Venkateswara Swamy, Kakumani V. Swamy, Kakumani Venkateswara SWAMY

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Dr. D.Y. Patil Vidyapeeth, Pune Savitribai Phule Pune University MIT Art, Design and Technology University The Barbara Ann Karmanos Cancer Institute Wayne State University

About

K. Venkateswara Swamy is an author at Dr. D.Y. Patil Vidyapeeth, Pune specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	927
2	Biochemistry	9	9	485
3	Natural Sciences	7	7	277
4	Chemical Biology	3	3	113
5	Cell Biology	2	2	73

K. Venkateswara Swamy

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice Subhash Padhyé, Sanjeev Banerjee, Deepak Chavan, Pharmaceutical Research Pharmacological StudyBiochemistryMedicineCyclooxygenase-2 InhibitorPharmacology	2009	145
Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer Prasad Dandawate, Alok Vyas, Aamir Ahmad, Pharmaceutical Research Inclusion ComplexPancreatic CancerMedicineTumor TargetingAnti-cancer Agent	2012	131
Molecular docking and simulation studies on SARS-CoV-2 M<sup>pro</sup> reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19 Kiran Bharat Lokhande, Sayali Doiphode, Renu Vyas, Journal of Biomolecular Structure and Dynamics	2020	122
Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells Prasad Dandawate, E. M. Khan, Subhash Padhyé, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineBreast Cancer CellsPharmacologyAnti-cancer Agent	2012	98
Fluorinated 2′-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities Subhash Padhyé, Aamir Ahmad, Nikhil Oswal, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAnticancer ActivitiesBiochemistryNatural SciencesMedicine	2010	68
Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach Kiran Bharat Lokhande, Shuchi Nagar, K. Venkateswara Swamy Scientific Reports Cyclin D1Molecular BiologyChemical BiologyMolecular DynamicsMedicinal Chemistry	2019	54
Synthesis, characterization and anti-tumor activity of novel thymoquinone analogs against pancreatic cancer Yusufi Mujahid, Sanjeev Banerjee, Momin Mohammad, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPancreatic CancerNovel Thymoquinone AnalogsMedicineAnti-cancer Agent	2013	52
Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan–CD44v6 pathway and inducing cytotoxicity in colon cancer cells Suniti Misra, Shibnath Ghatak, Neha Patil, Bioorganic & Medicinal Chemistry MedicineNovel Dual CyclooxygenasePharmacologyCell DeathCancer Cell Biology	2013	44
Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer Kiran Bharat Lokhande, Sangeeta Ballav, Rohit Singh Yadav, Journal of Biomolecular Structure and Dynamics Drug TargetPharmacotherapyChemical BiologyMolecular DynamicsMm/gbsa Approach	2020	44
Novel Aza-resveratrol analogs: Synthesis, characterization and anticancer activity against breast cancer cell lines Areej Siddiqui, Prasad Dandawate, Rukhsana A. Rub, Bioorganic & Medicinal Chemistry Letters Breast OncologyNovel Aza-resveratrol AnalogsMedicineAnticancer ActivityBreast Cancer	2012	42

Page 1